Mortality Analysis of ST Elevation Myocardial Infarction (STEMI) Patients in Belgium

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Universiteit Antwerpen
Sponsor:
Collaborator:
Belgian Government
Information provided by (Responsible Party):
M Claeys, Universiteit Antwerpen
ClinicalTrials.gov Identifier:
NCT00727623
First received: July 29, 2008
Last updated: March 15, 2014
Last verified: March 2014
  Purpose

The purpose of this observational study is to assess predictors of in-hospital mortality in patients with acute myocardial infarction admitted to Belgian hospitals.


Condition
Acute Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Observational Study to Assess Predictors of in Hospital Mortality in STEMI Patients Admitted in Belgian Hospitals

Resource links provided by NLM:


Further study details as provided by Universiteit Antwerpen:

Primary Outcome Measures:
  • all cause mortality [ Time Frame: one month ] [ Designated as safety issue: No ]

Estimated Enrollment: 5000
Study Start Date: July 2007
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with acute ST elevation myocardial infarction admitted in Belgian hospitals.

Criteria

Inclusion Criteria:

  • clinical diagnosis of acute myocardial infarction with ST elevation or left bundle branch blok pattern on ECG

Exclusion Criteria:

  • acute myocardial infarction as an acute complication of coronary intervention
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00727623

Contacts
Contact: Marc J Claeys, MD PhD 3238214706 marc.claeys@ua.ac.be
Contact: Christiaan M Vrints, MD PhD 3238214720 christiaan.vrints@ua.ac.be

Locations
Belgium
Centre Hospitalier de Jolimont Recruiting
La Louviere, Hainaut, Belgium, 7100
Contact: Antoine de Meester, MD    32 64 233011    antoine.demeester@skynet.be   
Sponsors and Collaborators
Universiteit Antwerpen
Belgian Government
Investigators
Principal Investigator: Marc J Claeys, MD.PhD University Hospital, Antwerp
  More Information

No publications provided by Universiteit Antwerpen

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: M Claeys, Prof dr, Universiteit Antwerpen
ClinicalTrials.gov Identifier: NCT00727623     History of Changes
Other Study ID Numbers: BIWAC-01
Study First Received: July 29, 2008
Last Updated: March 15, 2014
Health Authority: Belgium: Ministry of Social Affairs, Public Health and the Environment

Keywords provided by Universiteit Antwerpen:
acute coronary syndrome
myocardial infarction
predictors of mortality
reperfusion therapy

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on August 25, 2014